Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

We spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and lobbying group for the ...

EMA advisors at the Committee for Medicinal Products for Human Use (CHMP) recommended Sandoz’s adalimumab Humira biosimilar under three brand names – Halimatoz, Hefiya and Hyrimoz. The firm ...

The second part of our conversation with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and ...

Shares of Equillium (NASDAQ:EQ) soared 26% Thursday after the company and partner Biocon reported positive topline results from a Phase 2 study of the drug itolizumab in the treatment of moderate to ...

Organon (NYSE: OGN) today announced its results for the fourth quarter and full year ended December 31, 2024. “In 2024 we achieved our third year of constant currency revenue growth and delivered ...

With its flagship in Los Angeles and a newly established second headquarters in Dubai, ÂMÉ Living is no longer just a ...

Your brand's ability and willingness to solve pain points for current and potential customers can make or break your company's existence and relevance in the industry. To help brand leaders remain ...

Companies often change their names to reflect new directions, mergers, or to improve their image. In India, several companies have rebranded recently. For instance, in February 2025, Zomato ...

In working with these clients and helping them create narratives that stick, I’ve learned the key to successful brand storytelling isn’t necessarily about relying on your company’s name from ...

As we enter 2025, it is clearer than ever that in the back half of this decade, brand building and audience engagement will be rooted in the creation of brand-funded content and entertainment.